A prospective study shows PSMA PET/CT-guided targeted biopsy detects clinically significant prostate cancer in 37 percent of ...

PSMA PET/CT-targeted biopsy detects more clinically significant prostate cancer than systematic biopsy alone in men whose MRI ...

The scan found 91 percent of dangerous tumors and correctly cleared most men who didn’t need a biopsy at all.

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

A high PSA blood test can be worrying, but it cannot tell doctors for certain whether a man has prostate cancer. New research suggests a specialized scan could give doctors another important clue ...

Add Yahoo as a preferred source to see more of our stories on Google. The scan works by using a molecule that binds to prostate cancer cells, causing them to appear as bright spots on imaging A scan ...

A new study by the Medical University of Vienna found that a specialized form of imaging could identify 91% of prostate cancer cases without the need for a biopsy. Traditionally, a blood test can ...

A new review in Medical Oncology details how liquid biomarkers, advanced imaging, and artificial intelligence are transforming pre-biopsy discrimination of prostate cancer from benign disease.

Only 31% of patients with prostate cancer receiving radiation therapy had a successful CT simulation on the first attempt, while more than half required multiple scans on the same day and nearly 17% ...

PSMA PET/CT-targeted biopsy detects more clinically significant prostate cancer than systematic biopsy alone in men whose MRI findings are ...